The UK's Royal College of Nursing (RCN), which represents more than 500,000 nurses, has ended its commercial partnership with Teva UK. The RCN said due diligence found that some of Teva's operations, which have faced legal sanctions and public scrutiny, did not align with its values. Pro-Palestine groups had pressured the RCN, citing Teva's links to the Israeli military and its record of corporate misconduct.
A Teva spokesperson expressed disappointment, saying the company valued its longstanding partnership with the RCN and wanted further dialogue.
Teva UK will no longer sponsor the RCNi nursing leadership summit on migraine and headache services, scheduled for October 30, 2026.